133 related articles for article (PubMed ID: 14516130)
1. Diagnostic implications of telomerase activity in pleural effusions.
Dikmen G; Dikmen E; Kara M; Sahin E; Doğan P; Ozdemir N
Eur Respir J; 2003 Sep; 22(3):422-6. PubMed ID: 14516130
[TBL] [Abstract][Full Text] [Related]
2. Telomerase activity in pleural effusions: diagnostic significance.
Yang CT; Lee MH; Lan RS; Chen JK
J Clin Oncol; 1998 Feb; 16(2):567-73. PubMed ID: 9469342
[TBL] [Abstract][Full Text] [Related]
3. Limitations of detection of malignancy in pleural effusions using ELISA-based TRAP assay: comparison with cytological examination.
Lee WY
Cytopathology; 2005 Oct; 16(5):227-32. PubMed ID: 16181308
[TBL] [Abstract][Full Text] [Related]
4. [Diagnostic significance of combining telomerase activity with CYFRA21-1 level in differentiating malignant pleural effusion caused by lung cancer from benign pleural effusion].
Li H; Fu J; Xiu Y; Zhou Q
Zhongguo Fei Ai Za Zhi; 2010 Jun; 13(6):652-4. PubMed ID: 20681457
[TBL] [Abstract][Full Text] [Related]
5. [Comparison of the diagnostic value of telomerase activity with CEA level in benign and malignant pleural effusions].
Yang Z; Xie C
Zhonghua Jie He He Hu Xi Za Zhi; 2001 Apr; 24(4):201-3. PubMed ID: 11802962
[TBL] [Abstract][Full Text] [Related]
6. Different expression of FoxM1 in human benign and malignant pleural effusion.
Tang Z; Li H; Zhu H; Bai C
Med Oncol; 2015 Jan; 32(1):312. PubMed ID: 25491139
[TBL] [Abstract][Full Text] [Related]
7. Comparison of telomerase activity between malignant and tuberculous pleural effusions.
Maneechotesuwan K; Lertworawiwat A; Tscheikuna J; Wamanuttajinda V
J Med Assoc Thai; 2006 Nov; 89 Suppl 5():S46-54. PubMed ID: 17718245
[TBL] [Abstract][Full Text] [Related]
8. Diagnostic implications of telomerase activity in pleural effusions.
Garcia-Pachon E; Padilla-Navas I
Eur Respir J; 2004 Apr; 23(4):653-4. PubMed ID: 15083771
[No Abstract] [Full Text] [Related]
9. Detection of telomerase activity in bronchial lavage as an adjunct to cytological diagnosis in lung cancer.
Dikmen E; Kara M; Dikmen G; Cakmak H; Dogan P
Eur J Cardiothorac Surg; 2003 Feb; 23(2):194-9; discussion 199-20. PubMed ID: 12559342
[TBL] [Abstract][Full Text] [Related]
10. Differentiating between malignant and idiopathic pleural effusions: the value of diagnostic procedures.
Alemán C; Sanchez L; Alegre J; Ruiz E; Vázquez A; Soriano T; Sarrapio J; Teixidor J; Andreu J; Felip E; Armadans L; Fernández De Sevilla T
QJM; 2007 Jun; 100(6):351-9. PubMed ID: 17525131
[TBL] [Abstract][Full Text] [Related]
11. Evaluation of Exudative Pleural Effusions: A Multicenter, Prospective, Observational Study.
Ak G; Metintas S; Taskın AN; Uzel Sener M; Soyler Y; Yilmaz M; Turna A; Akin Kabalak P; Bilaceroglu S; Koksal D; Yilmaz Demirci N; Sogukpinar O; Boga S; Ercelik M; Karadeniz G; Polat G; Guldaval F; Aka Akturk U; Yilmaz S; Ogan N; Yilmaz S; Esendagli D; Caglayan B; Zeybek A; Durmus Kocak N; Mutlu P; Atinkaya Baytemir C; Sarbay I; Yilmaz U; Metintas M
Lung; 2022 Dec; 200(6):807-815. PubMed ID: 36173482
[TBL] [Abstract][Full Text] [Related]
12. Potential diagnostic value of methylation profile in pleural fluid and serum from cancer patients with pleural effusion.
Benlloch S; Galbis-Caravajal JM; Martín C; Sanchez-Paya J; Rodríguez-Paniagua JM; Romero S; Mafe JJ; Massutí B
Cancer; 2006 Oct; 107(8):1859-65. PubMed ID: 16983705
[TBL] [Abstract][Full Text] [Related]
13. [Application of combined telomerase activity analysis and immunocytochemistry in cytopathologic diagnosis].
Liu Y; Xu ML; Wang J; Wu BQ; Zhong HH; Fang WG
Zhonghua Bing Li Xue Za Zhi; 2012 Mar; 41(3):181-5. PubMed ID: 22800482
[TBL] [Abstract][Full Text] [Related]
14. Diagnostic usefulness of tumour marker levels in pleural effusions of malignant and benign origin.
Kuralay F; Tokgöz Z; Cömlekci A
Clin Chim Acta; 2000 Oct; 300(1-2):43-55. PubMed ID: 10958862
[TBL] [Abstract][Full Text] [Related]
15. Use of a panel of tumor markers (carcinoembryonic antigen, cancer antigen 125, carbohydrate antigen 15-3, and cytokeratin 19 fragments) in pleural fluid for the differential diagnosis of benign and malignant effusions.
Porcel JM; Vives M; Esquerda A; Salud A; Pérez B; Rodríguez-Panadero F
Chest; 2004 Dec; 126(6):1757-63. PubMed ID: 15596670
[TBL] [Abstract][Full Text] [Related]
16. The value of exfoliative cell cytology in the diagnosis of exudative pleural effusions.
Tetikkurt C; Yılmaz N; Tetikkurt S; Gundogdu Ş; Disci R
Monaldi Arch Chest Dis; 2018 Sep; 88(3):944. PubMed ID: 30203633
[TBL] [Abstract][Full Text] [Related]
17. [Diagnostic value of DNA, RNA and proliferating cell nuclear antigen examination in malignant pleural effusions by flow cytometry].
Wang LX; Chen WX; Wu J; Chen SX; Huang XY; Chen YF
Zhonghua Jie He He Hu Xi Za Zhi; 2006 Dec; 29(12):804-7. PubMed ID: 17327081
[TBL] [Abstract][Full Text] [Related]
18. Detection of malignant effusions: comparison of a telomerase assay and cytologic examination.
Braunschweig R; Yan P; Guilleret I; Delacretaz F; Bosman FT; Mihaescu A; Benhattar J
Diagn Cytopathol; 2001 Mar; 24(3):174-80. PubMed ID: 11241900
[TBL] [Abstract][Full Text] [Related]
19. Telomerase activity in effusions: a comparison between telomere repeat amplification protocol in situ and conventional telomere repeat amplification protocol assay.
Hansson M; Zendehrokh N; Ohyashiki J; Ohyashiki K; Westman UB; Roos G; Dejmek A
Arch Pathol Lab Med; 2008 Dec; 132(12):1896-902. PubMed ID: 19061286
[TBL] [Abstract][Full Text] [Related]
20. Diagnostic accuracy of human telomerase reverse transcriptase mRNA in malignant pleural effusions: A preliminary report for in situ hybridization detection.
Shu J; Sun GY; Liu AP; Liu J
Clin Chim Acta; 2007 Jun; 381(2):131-5. PubMed ID: 17399696
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
